American Society of Hematology

SHERPA: Blue

People

  1. Palomba
    Palomba
  2. Zelenetz
    Zelenetz
  3. Hamlin
    Hamlin
  4. Noy
    Noy
  5. Horwitz
    Horwitz
  6. Salles
    Salles
  7. Kumar
    Kumar
  8. Moskowitz
    Moskowitz
  9. Shah
    Shah
  10. Perales
    Perales

Groups

  1. Center for Hematologic Malignancies (207)
  2. Department of Medicine (207)
  3. Hematologic Malignancies, Division of (207)
  4. Lymphoma (207)
  5. Hematology-Oncology Fellows (126)
  6. Survivorship Research (103)
  7. Epidemiology and Biostatistics (83)
  8. Sloan Kettering Institute Postdocs (83)
  9. Population Sciences Research Program (77)
  10. GSK Faculty (76)
Search Within
  1. "Maria Palomba"
Formats
  1. Meeting Abstract (174)
  2. Journal Article (28)
  3. Research Letter (2)
  4. Correspondence (1)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (207)
  2. Department of Medicine (207)
  3. Hematologic Malignancies, Division of (207)
  4. Lymphoma (207)
  5. Hematology-Oncology Fellows (126)
  6. Survivorship Research (103)

More Groups

People
  1. Maria Palomba (207)
  2. Andrew Zelenetz (88)
  3. Ariela Noy (78)
  4. Paul Hamlin (78)
  5. Steven Horwitz (69)
  6. Gilles Salles (67)

More People

Years
  1. 2025 (2)
  2. 2024 (33)
  3. 2023 (39)
  4. 2022 (16)
  5. 2021 (19)
  6. 2020 (17)

More Years

Publications
  1. Blood (187)
  2. Blood Advances (19)
  3. Hematology-American Society of Hematology Education Program (1)

Results (207)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Optimizing therapeutic outcome of CD19(T2)28z1XX chimeric antigen receptor (CAR) T in adult patients with large B-cell lymphoma through a quantitative medicine approach
    Meeting Abstract

    Dey, A.; Li, J.; Park, J. H.; Sellner, L.; Sundaresan, V.; Palomba, M. L.; Mansilla-Soto, J.; Senechal, B.; Wang, X.; Sikder, D. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma
    Meeting Abstract

    Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-Hodgkin Lymphoma (NHL): Timed up and go test (TUG) time emerges as a functional vital sign
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Truong, R.; Qiu, A.; Amador, W. R.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save